Literature DB >> 31924561

Smoking cessation and weight change in relation to cardiovascular disease incidence and mortality in people with type 2 diabetes: a population-based cohort study.

Gang Liu1, Yang Hu2, Geng Zong3, An Pan4, JoAnn E Manson5, Kathryn M Rexrode6, Eric B Rimm7, Frank B Hu7, Qi Sun8.   

Abstract

BACKGROUND: To reduce their overall substantially increased risk of cardiovascular disease and premature mortality, smoking cessation is especially important for people with diabetes. However, the effect of weight change after quitting smoking on the long-term health consequences of smoking cessation is unclear. We aimed to examine smoking cessation and subsequent weight change in relation to incident cardiovascular disease events and mortality among adults with type 2 diabetes.
METHODS: In this population-based cohort study, we analysed data from people with type 2 diabetes from two prospective cohorts in the USA: the Nurses' Health Study (1976-2014) and the Health Professionals Follow-Up Study (1986-2014). We included participants from both cohorts who either had prevalent type 2 diabetes or were diagnosed during the study, and who were either current smokers or never smokers without cardiovascular disease or cancer at diagnosis of diabetes. Information on demographics, newly diagnosed diseases, medical history, and lifestyle factors, including smoking status and weight change, was updated every 2 years through validated questionnaires. We assessed the incidence of cardiovascular disease and all-cause and cause-specific mortality among recent quitters (within 6 years of stopping) and long-term quitters (>6 years) associated with weight change within 6 years of smoking cessation among people with type 2 diabetes. We did a multivariable-adjusted Cox proportional hazard models to estimate hazard ratios (HRs) for the associations of smoking cessation and weight change on the outcomes.
FINDINGS: Of 173 229 total cohort participants (121 700 from the Nurses' Health Study and 51 529 from the Health Professionals Follow-Up Study), 10 809 people with type 2 diabetes were included in the incident cardiovascular disease analysis and 9688 were included in the mortality analysis. 2580 incident cases of cardiovascular disease occurred during 153 166 person-years of follow-up, and 3827 deaths occurred during 152 811 person-years of follow-up. Recent quitters (2-6 consecutive years since smoking cessation) without weight gain within the first 6 years of quitting had a significantly lower risk of cardiovascular disease than people who continued to smoke (multivariable-adjusted HR 0·83 [95% CI 0·70-0·99] among all recent quitters, 0·77 [0·62-0·95] among recent quitters without weight gain, 0·99 [0·70-1·41] among recent quitters with weight gain of 0·1-5·0 kg, 0·89 [0·65-1·23] among recent quitters with weight gain of >5·0 kg, and 0·72 [0·61-0·84] among longer-term quitters [>6 consecutive years since smoking cessation]). Weight gain within 6 years after smoking cessation did not attenuate the inverse relation between long-term cessation and all-cause mortality (multivariable-adjusted HR 0·69 [95% CI 0·58-0·82] among long-term quitters without weight gain, 0·57 [0·45-0·71] among long-term quitters with weight gain of 0·1-5·0 kg, and 0·51 [0·42-0·62] among long-term quitters with weight gain of >5·0 kg), with similar results observed for cardiovascular disease and cancer mortality.
INTERPRETATION: Smoking cessation without subsequent weight gain is associated with a reduced risk of cardiovascular disease and mortality among smokers with type 2 diabetes. Weight gain after smoking cessation attenuates the reduction in risk of developing cardiovascular disease, but does not attenuate the beneficial effect of smoking cessation with respect to mortality. These findings confirm the overall health benefits of quitting smoking among people with type 2 diabetes, but also emphasise the importance of weight management after smoking cessation to maximise its health benefits. FUNDING: US National Institutes of Health.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 31924561      PMCID: PMC6986932          DOI: 10.1016/S2213-8587(19)30413-9

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


  30 in total

Review 1.  Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus: A Meta-Analysis and Systematic Review.

Authors:  An Pan; Yeli Wang; Mohammad Talaei; Frank B Hu
Journal:  Circulation       Date:  2015-08-26       Impact factor: 29.690

2.  Effects of smoking cessation and weight gain on cardiovascular disease risk factors in Asian male population.

Authors:  Chan Yoon; Eurah Goh; Sang Min Park; Belong Cho
Journal:  Atherosclerosis       Date:  2009-07-15       Impact factor: 5.162

Review 3.  9. Cardiovascular Disease and Risk Management.

Authors: 
Journal:  Diabetes Care       Date:  2017-01       Impact factor: 19.112

4.  Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus.

Authors:  Wael K Al-Delaimy; JoAnn E Manson; Caren G Solomon; Ichiro Kawachi; Meir J Stampfer; Walter C Willett; Frank B Hu
Journal:  Arch Intern Med       Date:  2002-02-11

5.  Metabolic effects of smoking cessation.

Authors:  Kindred K Harris; Mohan Zopey; Theodore C Friedman
Journal:  Nat Rev Endocrinol       Date:  2016-09-30       Impact factor: 43.330

6.  Smoking cessation, weight gain, and risk of stroke among postmenopausal women.

Authors:  Paul C Dinh; Lauren A Schrader; Catherine J Svensson; Karen L Margolis; Brian Silver; Juhua Luo
Journal:  Prev Med       Date:  2018-10-22       Impact factor: 4.018

7.  Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.

Authors:  K Eeg-Olofsson; J Cederholm; P M Nilsson; B Zethelius; L Nunez; S Gudbjörnsdóttir; B Eliasson
Journal:  Diabetologia       Date:  2008-11-05       Impact factor: 10.122

8.  Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes.

Authors:  Carole Clair; Nancy A Rigotti; Bianca Porneala; Caroline S Fox; Ralph B D'Agostino; Michael J Pencina; James B Meigs
Journal:  JAMA       Date:  2013-03-13       Impact factor: 56.272

9.  Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes.

Authors:  W C Willett; A Green; M J Stampfer; F E Speizer; G A Colditz; B Rosner; R R Monson; W Stason; C H Hennekens
Journal:  N Engl J Med       Date:  1987-11-19       Impact factor: 91.245

10.  The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study.

Authors:  Deborah Lycett; Linda Nichols; Ronan Ryan; Amanda Farley; Andrea Roalfe; Mohammed A Mohammed; Lisa Szatkowski; Tim Coleman; Richard Morris; Andrew Farmer; Paul Aveyard
Journal:  Lancet Diabetes Endocrinol       Date:  2015-04-29       Impact factor: 32.069

View more
  12 in total

1.  Integrative functional linear model for genome-wide association studies with multiple traits.

Authors:  Yang Li; Fan Wang; Mengyun Wu; Shuangge Ma
Journal:  Biostatistics       Date:  2022-04-13       Impact factor: 5.899

2.  Weight Change, Lifestyle, and Mortality in Patients With Type 2 Diabetes.

Authors:  Jinbo Hu; Yang Hu; Ellen Hertzmark; Chen Yuan; Gang Liu; Meir J Stampfer; Eric B Rimm; Frank B Hu; Molin Wang; Qi Sun
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

Review 3.  Impact of stopping smoking on metabolic parameters in diabetes mellitus: A scoping review.

Authors:  Magdalena Walicka; Cristina Russo; Michael Baxter; Isaac John; Grazia Caci; Riccardo Polosa
Journal:  World J Diabetes       Date:  2022-06-15

4.  Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial.

Authors:  Cristina Russo; Magdalena Walicka; Pasquale Caponnetto; Fabio Cibella; Marilena Maglia; Angela Alamo; Davide Campagna; Lucia Frittitta; Maurizio Di Mauro; Grazia Caci; Arkadiusz Krysinski; Edward Franek; Riccardo Polosa
Journal:  JAMA Netw Open       Date:  2022-06-01

5.  The association of genetic susceptibility to smoking with cardiovascular disease mortality and the benefits of adhering to a DASH diet: The Singapore Chinese Health Study.

Authors:  Tingting Geng; Xuling Chang; Ling Wang; Gang Liu; Jianjun Liu; Chiea Chuen Khor; Nithya Neelakantan; Jian-Min Yuan; Woon-Puay Koh; An Pan; Rajkumar Dorajoo; Chew-Kiat Heng
Journal:  Am J Clin Nutr       Date:  2022-08-04       Impact factor: 8.472

Review 6.  Association of magnitude of weight loss and weight variability with mortality and major cardiovascular events among individuals with type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  Shan Huang; Ke Shi; Yan Ren; Jin Wang; Wei-Feng Yan; Wen-Lei Qian; Zhi-Gang Yang; Yuan Li
Journal:  Cardiovasc Diabetol       Date:  2022-05-16       Impact factor: 8.949

7.  Temporal relationship among adiposity, gut microbiota, and insulin resistance in a longitudinal human cohort.

Authors:  Kui Deng; Menglei Shuai; Zheqing Zhang; Zengliang Jiang; Yuanqing Fu; Luqi Shen; Ju-Sheng Zheng; Yu-Ming Chen
Journal:  BMC Med       Date:  2022-05-19       Impact factor: 11.150

8.  Lifetime employment, tobacco use, and alcohol consumption trajectories and cardiovascular diseases in old age.

Authors:  Ignacio Madero-Cabib; Ariel Azar; Claudia Bambs
Journal:  SSM Popul Health       Date:  2021-01-25

Review 9.  Cardiometabolic Morbidity and Mortality with Smoking Cessation, Review of Recommendations for People with Diabetes and Obesity.

Authors:  Katarina Kos
Journal:  Curr Diab Rep       Date:  2020-12-08       Impact factor: 4.810

10.  Association of weight change following smoking cessation with the risk of tuberculosis development: A nationwide population-based cohort study.

Authors:  Seung Hoon Kim; Yong-Moon Park; Kyungdo Han; Seung Hyun Ko; Shin Young Kim; So Hyang Song; Chi Hong Kim; Kyu Yeon Hur; Sung Kyoung Kim
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.